Cogentech is a private limited company whose mission is to provide technological services for the post-genomic era to researchers and clinicians.
Cogentech's services are dedicated to members of the international scientific community and clinicians who wish to use them for diagnostic purposes.
Model 231
- Cogentech has adopted the Model 231 and nominated Vigilance Body as requested by the legislative decree n. 231of June 8th 2001.
- This law introduced in the Italian legislative framework the notion of administrative liability of legal entities deriving from offences. According to the law, legal entities such as Cogentech may be held liable for any offence committed in the interest or to the advantage of the company itself by any administrator, manager or employee of the company.
- However, companies may adopt organizational, management and control models designed to prevent such offences. This is the role of the Model 231 and the Vigilance Body.
Certification UNI EN ISO 9001:2015 n. IT256850
Download certification
Auditor
- Price Waterhouse Coopers
Vigilance Body
- Avv. Andrea Gottardo
- Dott. Alberto Bettinardi
- Dott. Ambrogio Brambilla
odv [@] cogentech.it
Organizational chartCogentech S.R.L. Società Benefit a Socio Unico soggetta all’attività di direzione e coordinamento di IFOM - Istituto Fondazione di Oncologia Molecolare ETS
Registered Office: via Adamello 16, 20139 Milan, Italy – Fully paid up share Capital 1.100.000 €
Local Unit: c/o Parco Scientifico e Tecnologico della Sicilia S.c.p.a. - Z.I. Blocco Palma I, Stradale V. Lancia, 57 - 95121 Catania
Tax Code, VAT and Milano, Monza, Brianza and Lodi Chamber of Commerce Register n. 04641450962 - R.E.A. MI-1763886
